RAACX | VGSLX | RAACX / VGSLX | |
Total Expense Ratio | 3.53 | 0.13 | 2,715% |
Annual Report Gross Expense Ratio | 3.69 | 0.13 | 2,838% |
Fund Existence | 5 years | 24 years | - |
Gain YTD | -17.589 | 5.004 | -352% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 44.8M | 63.8B | 0% |
Annual Yield % from dividends | 0.22 | 3.89 | 6% |
Returns for 1 year | -17.06 | 8.26 | -207% |
Returns for 3 years | -28.97 | 9.88 | -293% |
Returns for 5 years | N/A | 42.02 | - |
Returns for 10 years | N/A | 65.35 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
APCB | 29.40 | 0.02 | +0.07% |
ActivePassive Core Bond ETF | |||
WTID | 13.64 | N/A | N/A |
MicroSectors™ Energy -3X Invrs Lvrgd ETN | |||
SPLG | 74.65 | N/A | N/A |
SPDR® Portfolio S&P 500® ETF | |||
BIB | 52.55 | -0.07 | -0.14% |
ProShares Ultra Nasdaq Biotechnology | |||
FICS | 39.48 | -0.15 | -0.38% |
First Trust Intl Developed Cap Strth ETF |